Pfizer puts Foundation Medicine at the center of its cancer companion diagnostic strategy | FierceBiotech
Jan 16, 2018 @ 17:08

Pfizer has struck a broad cancer companion diagnostic deal with Foundation Medicine. The alliance will see Foundation Medicine use pan-cancer test FoundationOne CDx as a companion diagnostic for Pfizer drugs.

Sourced through from:

Leave a Reply